Good morning,
We have fourteen deals this week, taking in Dexcom's first manufacturing facility in Europe, a 20,000 sq m interdisciplinary research building completion in Hamburg, and a synthetic DNA company moving into a 37,000 sq ft Cambridge laboratory. Let's get into it.
In today's free edition:
🇮🇪 Dexcom completes its manufacturing facility in Galway
🇩🇪 University Medical Center Hamburg-Eppendorf completes its 18,000 sq m research building
🇬🇧 4basebio leases 37,000 sq ft Q-Arc building at Bar Hill, Cambridge
🔒 For paying members only:
🇩🇪 European Science Park Group returns to profitability with €0.5 million result in 2025
🇩🇪 Hauck Aufhäuser Lampe acquires Am Sonnengarten healthcare centre in Mannheim
🇩🇪 TSC Real Estate acquires Sonnenhof health centre in Duisburg
🇩🇪 State Building Authority Ulm issues fit-out contract for Bundeswehr Hospital extension
🇮🇪 West Pharmaceutical Services opens 15,330 sq m expansion at Dublin's Damastown facility
🇮🇪 Bartra seeks permission for 171-bed Cookstown transitional care facility in Dublin
🇸🇪 Thermo Fisher Scientific opens 8,000 sq m distribution centre in Uppsala
🇳🇱 Princess Máxima Center prepares 5,000 sq m innovation wing in Utrecht
🇬🇧 Ki Hydrogen to relocate into 1 Portal Way lab hub in North Acton
🇫🇷 Signadori Bio joins The HIVE Innovation Center at Campus Grand Parc in Villejuif
🇬🇧 Norwich Research Park wins planning for new 21,000 sq m Main Laboratory Building
Subscribe here to unlock.
Enjoy today's newsletter,
— Stephen Ryan
Dexcom completes first European manufacturing facility in Galway
Dexcom has completed its first manufacturing facility in Europe, a medical devices development of around 30,000 sq m in Galway delivered over a 25-month programme by John Paul Construction.
The facility includes cleanrooms, laboratory and engineering spaces and a four-storey office building, and will manufacture real-time continuous glucose monitoring systems for diabetes management.
RKD acted as architect.
University Medical Center Hamburg-Eppendorf completes research building
A six-storey interdisciplinary research and laboratory building of roughly 18,000 sq m has been completed on a 3,900 sq m site at the University Medical Center Hamburg-Eppendorf.
The development brings together Campus Forschung II and the Hamburg Center for Translational Immunology in two parallel brick volumes linked by a central connecting element.
The building provides around 150 laboratory units for immunity, infection and inflammation research, with flexible laboratory zones on upper floors and seminar, event and meeting spaces at ground level.
The architects are Telluride Architektur.
In addition to this newsletter, we deliver bespoke research and strategic analysis for investors and developers — from acquisition support to market mapping and custom reporting. Hit reply to discuss your next project.
4basebio leases 37,000 sq ft Q-Arc building at Bar Hill, Cambridge
Synthetic DNA manufacturer 4basebio has leased Q-Arc, a 37,000 sq ft building at Bar Hill, Cambridge, from Peterhouse, the University of Cambridge's oldest college.
The publicly listed company, which specialises in nucleic acids for next-generation therapeutics, will retrofit the building from office accommodation into a CL2 laboratory and research and development facility.
Occupation is expected in late summer 2026. Tydus Peterborough Real Estate and Bidwells acted for Peterhouse; Creative Places acted for 4basebio.
